Quick Answer
INTEGRATED BIOPHARMA INC reported Earnings Per Share Diluted of $0.03 per share for the year ending 2025.
- This data is from INTEGRATED BIOPHARMA INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), INTEGRATED BIOPHARMA INC's Earnings Per Share Diluted has grown by 123.1%.
- Historical annual values: Fiscal year 2025: $0.03 per share | Fiscal year 2024: $0.00 per share | Fiscal year 2023: $0.00 per share | Fiscal year 2022: $0.12 per share | Fiscal year 2021: $0.25 per share | Fiscal year 2020: $0.13 per share | Fiscal year 2019: $0.06 per share | Fiscal year 2018: $0.02 per share | Fiscal year 2017: $0.10 per share | Fiscal year 2016: $0.05 per share | Fiscal year 2015: $0.02 per share | Fiscal year 2014: $0.01 per share | Fiscal year 2013: $0.00 per share | Fiscal year 2012: $0.13 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: